UT Southwestern to hold chest wellness day for trans community next week

A Chest & Breast Wellness Day next Saturday at UT Southwestern will provide transgender men and women and masculine women an opportunity to have a comfortable environment for breast cancer screenings.

Nell Gaither, president of Trans Pride Initiative, said she planned the event so gender non-conforming individuals could have good access to healthcare without feeling uncomfortable or facing discrimination at a doctor’s office.

The event is from 7:30 a.m. to noon Oct. 20 at UT Southwestern Medical Center, 2201 Inwood Road on the third floor.  Screenings will remain open until 5 p.m. if there are enough appointments or people waiting.

Appointments can be made by calling 214-645-2526, but walk-ins will also be accepted. Gaither said people can even call the morning of the event to schedule an appointment.

Screening costs are covered for Dallas and Tarrant County residents if someone’s insurance won’t cover the cost or if someone doesn’t have insurance. Residents of other counties should call first.

We’ll have more information about Trans Pride Initiative and upcoming healthcare plans in next week’s Dallas Voice, but we wanted to get the information about the appointments out early.

—  Anna Waugh

UT Southwestern marks HIV Vaccine Awareness Day

DAVID TAFFET | Staff Writer
taffet@dallasvoice.com

UT Southwestern’s Dr. Mamta Jain will be at ilume on May 18 to give a presentation on the necessity for an HIV vaccine.

Jain is heading a clinical trial of a vaccine that may help researchers understand how the immune system may prevent HIV. They are trying to understand why some people who are HIV-positive develop AIDS while others do not.

The study began last September but participants for the trial are still needed.

Jain said that participants cannot contract HIV from the vaccine.

“The vaccine is composed of man-made proteins that are found in HIV, not the HIV virus itself,” Jain said. “The vaccine cannot cause infection.”

Participants will receive three shots of either the vaccine or a placebo plus a booster shot in the first six months. Then they will return every three months for an HIV test, interview and risk-reduction counseling.

The study runs for three years.

Investigators are looking for gay men or transgender women who have sex with men who are between the ages of 18 and 5o and are HIV-negative. Testing to qualify would be done at UT Southwestern.

Jain will speak in the Great Room and Champagne Lounge at ilume, 4123 Cedar Springs Road on May 18 at 5-7 p.m. Free.

—  John Wright

UTSW seeks volunteers for HIV vaccine trial

Researchers at UT Southwestern Medical Center announced on Friday, Sept. 10, that they are looking for people at high risk of contracting HIV to participate in a three-year, nationwide clinical trial intended to determine whether a combination of two potential HIV vaccines will stimulate an immune response against the virus.

Dr. Mamta Jain, assistant professor of internal medicine at UT Southwestern, will be principal investigator for the study locally. She said the trial is designed to determine whether the new combo-vaccine will reduce the HIV viral load of people who subsequently become infected with HIV, preventing the onset of AIDS. She said that the combo-vaccine is composed of man-made proteins found in HIV, not the virus itself, and stressed that participants could not contract HIV from the vaccine. She also said the combo vaccine is designed to produce T-cells and antibody responses against HIV, and that it has proven safe in animals and hundreds of human volunteers during previous clinical trials.

The trial, known as the HVTN 505 study, will include 1,350 volunteers nationally who will be assigned randomly to receive either the combo vaccine or a placebo. Researchers with the study locally are looking for 40-50 volunteers to participate through UT Southwestern. The next closest site where the trial is being conducted is the Alabama Vaccine Research Clinic in Birmingham, about 650 miles from Dallas.

Investigators are looking for healthy, HIV-negative men between 18 and 45 who have sex with men, and transgender women who have sex with men. Participants will receive three shots of the combo vaccine or a placebo, plus a booster shot, within the first six months. They will then be asked to return every three months over the next three years for an HIV test, an interview and risk reduction counseling.

The study, funded by the HIV Vaccine Trials Network, “may help us better understand why some people develop AIDS and others don’t,” Jain said. “If you could prevent people from getting sick with AIDS, that’s a tremendous accomplishment.”

For more information about the clinical trial, call 214-590-0610 or 214-590-0603, or go online to HopeTakesAction.org. Go online to UTSouthwestern.org/InfectiousDiseases for more information about UT Southwestern’s clinical services for infectious diseases.

—  admin